{{Rsnum
|rsid=4907479
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Chromosome=13
|Orientation=plus
|Gene=MCF2L
|position=113004794
|Gene_s=MCF2L
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 6.2 | 39.8 | 54.0
| HCB | 10.9 | 43.8 | 45.3
| JPT | 12.4 | 41.6 | 46.0
| YRI | 0.7 | 18.4 | 81.0
| ASW | 1.8 | 17.5 | 80.7
| CHB | 10.9 | 43.8 | 45.3
| CHD | 15.6 | 34.9 | 49.5
| GIH | 4.0 | 36.6 | 59.4
| LWK | 4.5 | 32.7 | 62.7
| MEX | 10.3 | 34.5 | 55.2
| MKK | 3.2 | 48.7 | 48.1
| TSI | 5.0 | 36.6 | 58.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=24163127
  |Trait=Bladder cancer
  |Title=Genome-wide association study identifies multiple loci associated with bladder cancer risk.
  |RiskAllele=
  |Pval=3E-6
  |OR=1.13
  |ORtxt=[1.07-1.18]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}